Marina

About Marina

This author has not yet filled in any details.
So far Marina has created 10 blog entries.

First Orientation Event for YOUNG RESIST and Elections for the YOUNG RESIST Board

On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST researchers, including doctoral candidates, early-career postdocs, and clinical scientists, with the goal of strengthening networking among early-career researchers in the RESIST Cluster of Excellence, promoting their development, and creating additional opportunities for active participation. The participants were welcomed by Prof. Dr. Reinhold Förster, Head of Immunology and Spokesperson for the RESIST Cluster of Excellence. Project Coordinator Dr. Eugenia Gripp led the program. At the start of the event, the cluster’s [...]

2026-03-17T10:10:50+01:00 17. March 2026|

Dr. Lennart Riemann awarded “Infection Biology PhD Prize”

Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with €1,000. The prize recognizes his dissertation entitled "Systems Immunology Approaches for Human Immune Profiling in Vaccination and Aging," in which he investigated modern systems immunology methods for analyzing human immune responses. Riemann completed his medical studies in Heidelberg before moving to Hanover as part of the TITUS Clinician Scientist Program. There, he conducted research at the Clinic for Pediatric Pneumology, Allergology, and Neonatology under the direction of Prof. Dr. Gesine Hansen and at the Institute of Immunology under Prof. Dr. Reinhold [...]

2026-03-17T09:50:49+01:00 10. March 2026|

Precision Medicine for the Liver

RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease "primary sclerosing cholangitis (PSC)" affects approximately one in 10,000 people in Germany. Characterized by chronic inflammation of the bile ducts, PSC frequently leads to severe complications, including the need for liver transplantation. To date, treatment options are limited to managing symptoms, often through the use of broad-spectrum antibiotics, which may promote the development of antimicrobial resistance. Researchers at Hannover Medical School and the Helmholtz Centre for Infection Research are now developing an innovative therapeutic approach within the “StopPSC” project. The focus is on the [...]

2026-02-24T10:28:00+01:00 17. February 2026|

How does Long COVID develop? A new piece of the puzzle identified

Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li at the Centre for Individualised Infection Medicine (CiiM) now provides new insights into potential molecular mechanisms underlying the condition. Yang Li is also a member of the RESIST Cluster of Excellence, as are other researchers who played a key role in the publication. Using modern single-cell analyses, the researchers identified a specific molecular state in immune cells that is associated with inflammatory processes as well as typical Long COVID symptoms [...]

2026-02-12T10:16:22+01:00 12. February 2026|

Researchers develop new approaches to treating chronic wounds

At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are painful, and restrict movement. At Hannover Medical School (MHH), Fulbright scholar Samuel Sung from the USA is now spending a year researching new therapeutic approaches to improve the healing of chronic wounds in collaboration with the team of Prof. Dr. Nico Lachmann, who is part of the RESIST research group. To this end, he is combining engineering with immunology and focusing on the use of specialized immune cells. Macrophages (scavenger [...]

2026-02-09T15:14:26+01:00 9. February 2026|
Go to Top